Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

14
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
14
Hyperglycemia01:29

Hyperglycemia

24
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
24
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Hypoglycemia01:26

Hypoglycemia

29
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
29
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

68
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
68
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

23
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cryopreserved and <i>in vivo-in vitro</i> validated human induced pluripotent stem cell blood-brain barrier model for reliable neurotoxicity assessment.

NAM journal·2026
Same author

Corrigendum to "Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC working group on CGM" [Clin. Chim. Acta 580 (2026) 120728].

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

[Gene doping: current test methods and analytical challenges].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same author

Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography-High-Resolution Mass Spectrometry for Doping Control Purposes.

Drug testing and analysis·2026
Same author

Detection of the GH Analogue Redalsomatropin Alfa in Sports Drug Testing: Immunological Approaches and LC-HRMS/MS.

Drug testing and analysis·2026

Related Experiment Video

Updated: Apr 28, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K

Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects.

Markolf Hanefeld1, Stefan Sulk2, Matthias Helbig2

  • 1Study Centre Prof. Hanefeld, GWT-TUD GmbH, Dresden, Germany hanefeld@gwtonline-zks.de.

Journal of Diabetes Science and Technology
|May 31, 2014
PubMed
Summary
This summary is machine-generated.

Continuous glucose monitoring reveals abnormal glucose tolerance (AGT) is better characterized by glucose variability and post-meal glucose excursions than HbA1c. These findings highlight AGT

Keywords:
HbA1ccontinuous glucose monitoringglucose homeostasisglycemic variabilitynormal glucose toleranceprediabetes

More Related Videos

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.5K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.5K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Diabetes Research

Background:

  • Current criteria for normal glucose tolerance (NGT) and abnormal glucose tolerance (AGT) rely on HbA1c and oral glucose tolerance tests (OGTT).
  • These traditional markers may not fully capture the nuances of glucose metabolism.

Purpose of the Study:

  • To compare diurnal glucose profiles and glucose variability (GV) between individuals with NGT and AGT.
  • To assess if continuous glucose monitoring (CGM) can better differentiate glucose homeostasis than existing criteria.

Main Methods:

  • A cohort of 28 NGT and 42 AGT individuals (classified by 75g OGTT) underwent CGM.
  • Participants were matched for age, BMI, and comorbidities.
  • Diurnal profiles, glucose excursion post-test meal (TM), and GV metrics (SD, MAGE) were analyzed.

Main Results:

  • Despite similar HbA1c levels, AGT individuals showed significantly higher average interstitial glucose (AiG), 2-hour incremental area under the curve (iAUC), and post-meal glucose peaks compared to NGT.
  • Glucose variability metrics, including standard deviation (SD) and mean amplitude of glycemic excursion (MAGE), were significantly elevated in the AGT group.
  • CGM revealed significant differences in daytime AiG, postprandial glucose excursion, and postprandial peaks between NGT and AGT cohorts.

Conclusions:

  • Continuous glucose monitoring demonstrates significant differences in glucose dynamics between NGT and AGT individuals, even when matched for age, BMI, and comorbidities.
  • Glucose variability and post-meal glucose excursions, as measured by CGM, provide a more comprehensive characterization of impaired glucose homeostasis than HbA1c or 75g OGTT alone.